Antibodies Create Killer Bonds in Myeloma

Research output: Contribution to journalShort survey

1 Citation (Scopus)

Abstract

In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalCancer Cell
Volume31
Issue number3
DOIs
StatePublished - Mar 13 2017

Fingerprint

B-Cell Maturation Antigen
Plasma Cells
Multiple Myeloma
B-Lymphocytes
T-Lymphocytes
Antibodies
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Antibodies Create Killer Bonds in Myeloma. / Chesi, Marta; Fonseca, Rafael.

In: Cancer Cell, Vol. 31, No. 3, 13.03.2017, p. 305-307.

Research output: Contribution to journalShort survey

@article{cdd9433495d9437294fbe52eea37e16a,
title = "Antibodies Create Killer Bonds in Myeloma",
abstract = "In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.",
author = "Marta Chesi and Rafael Fonseca",
year = "2017",
month = "3",
day = "13",
doi = "10.1016/j.ccell.2017.02.011",
language = "English (US)",
volume = "31",
pages = "305--307",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Antibodies Create Killer Bonds in Myeloma

AU - Chesi, Marta

AU - Fonseca, Rafael

PY - 2017/3/13

Y1 - 2017/3/13

N2 - In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

AB - In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

UR - http://www.scopus.com/inward/record.url?scp=85015062776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015062776&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2017.02.011

DO - 10.1016/j.ccell.2017.02.011

M3 - Short survey

VL - 31

SP - 305

EP - 307

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -